KemPharm (NASDAQ:KMPH) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
KemPharm missed estimated earnings by 58.33%, reporting an EPS of $-0.19 versus an estimate of $-0.12.
Revenue was down $10.69 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 3.3% drop in the share price the next day.
Here’s a look at KemPharm’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.05 | -0.07 | -0.07 | 0.22 |
| EPS Actual | -0.05 | -0.08 | -0.06 | -0.40 |
| Revenue Estimate | 3.06M | 2.23M | 2.18M | 12.10M |
| Revenue Actual | 3.96M | 2.60M | 1.97M | 11.99M |
To track all earnings releases for KemPharm visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
